Avanza Fonder’s Royalty Pharma RPRX Stock Holding History

Avanza Fonder’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92.5K	Hold	1,649	–	–	﹤0.01%	433
2026 Q1	$79.1K	Buy	+1,649	New	+$72.2K	﹤0.01%	466

Other funds holding RPRX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

KMC

Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return

Avanza Fonder's RPRX Position: Q2 2026 in Review

Avanza Fonder held its Royalty Pharma (RPRX) position steady in Q2 2026 at 1,649 shares worth $92.5K. The position accounts for ﹤0.01% of the portfolio, ranked #433.

Avanza Fonder first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. 138 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Avanza Fonder held 1,649 shares of Royalty Pharma worth $92.5K as of Q2 2026.
Avanza Fonder left its Royalty Pharma share count unchanged in Q2 2026.
Royalty Pharma made up ﹤0.01% of Avanza Fonder's portfolio in Q2 2026, its #433 holding.
Avanza Fonder first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
138 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.